Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 13,298,000 | 13,466,000 | 12,906,000 | 13,703,000 | 13,168,000 |
| Cost of Goods | 2,694,000 | 2,916,000 | 2,563,000 | 3,256,000 | 2,844,000 |
| Gross Profit | 10,604,000 | 10,550,000 | 10,343,000 | 10,447,000 | 10,324,000 |
| Operating Expenses | 6,840,000 | 6,574,000 | 6,394,000 | 8,140,000 | 6,660,000 |
| Operating Income | 3,764,000 | 3,976,000 | 3,949,000 | 2,307,000 | 3,664,000 |
| Other Income | 413,000 | 551,000 | 178,000 | -1,353,000 | -79,000 |
| Pre-tax Income | 4,177,000 | 4,527,000 | 4,127,000 | 954,000 | 3,585,000 |
| Income Tax | 66,000 | 648,000 | 556,000 | -11,336,000 | 727,000 |
| Net Income Continuous | 4,111,000 | 3,879,000 | 3,571,000 | 12,288,000 | 2,858,000 |
| Net Income Discontinuous | 11,000 | N/A | -1,000 | N/A | N/A |
| Minority Interests | 8,000 | 7,000 | 9,000 | 15,000 | 18,000 |
| Net Income | $4,114,000 | $3,872,000 | $3,561,000 | $12,274,000 | $2,840,000 |
| EPS Basic Total Ops | 0.70 | 0.66 | 0.60 | 2.05 | 0.48 |
| EPS Basic Continuous Ops | 0.70 | 0.66 | 0.60 | 2.05 | 0.48 |
| EPS Diluted Total Ops | 0.69 | 0.65 | 0.59 | 2.03 | 0.47 |
| EPS Diluted Continuous Ops | 0.69 | 0.65 | 0.59 | 2.03 | 0.47 |
| EBITDA(a) | $5,378,000 | $5,538,000 | $5,516,000 | $3,881,000 | $5,230,000 |